jump to navigation jump to main content jump to footer
Corporate Governance Voting Rights

Changes at a Glance: 
Voting Rights Notifications

MIM Mondo Igel Media AG i.L. c/o RA Dobroschke: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution


MIM Mondo Igel Media AG i.L. c/o RA Dobroschke

05.03.2013 17:15

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


On March 04, 2013, Mr Klaus Thiele, Deutschland has informed us according
to Article 21, Section 1 of the WpHG that via shares his Voting Rights on
MIM Mondo Igel Media AG i.L., Hamburg, Deutschland, have fallen below the
3% threshold of the Voting Rights on February 28, 2013 and on that day
amounted to 0% (this corresponds to 0 Voting Rights).



05.03.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: MIM Mondo Igel Media AG i.L. c/o RA Dobroschke
Neuer Wall 75
20354 Hamburg
Germany
Internet: www.mim.ag

End of Announcement DGAP News-Service

---------------------------------------------------------------------------

Stay Informed

Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.

Registration is free of charge and can be revoked at any time.

Click here to register

Claudia Nickolaus
Head of Investor & Public Relations   

+49 30 232 566 800   
ir@medios.group

About Medios

Specialty Pharma

People & Career

Important Notice!

We have been informed of a fake listing of a cosmetic product on the TEMU platform in which Medios is falsely named as the distributor. Unfortunately, such unauthorized product listings are repeatedly observed on unreliable platforms like TEMU.

We would like to clarify: This offer is in no way connected to Medios and is not authorized. Our legal department has been informed.

Please obtain medical products exclusively through authorized and verified sources.

If you have any further questions, please contact: ir@medios.group

Back to Top